X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
hematology (35) 35
humans (35) 35
female (28) 28
male (28) 28
middle aged (26) 26
adult (25) 25
transplantation (24) 24
aged (18) 18
multiple myeloma (13) 13
hematology, oncology and palliative medicine (12) 12
immunology (12) 12
oncology (12) 12
stem cells (11) 11
transplantation, homologous (11) 11
treatment outcome (11) 11
bone-marrow-transplantation (10) 10
versus-host-disease (10) 10
diagnosis (9) 9
disease (9) 9
hematopoietic stem cell transplantation - adverse effects (9) 9
risk factors (9) 9
adolescent (8) 8
hematopoietic stem cell transplantation (8) 8
mortality (8) 8
recurrence (8) 8
stem-cell transplantation (8) 8
survival analysis (8) 8
young adult (8) 8
cancer (7) 7
follow-up studies (7) 7
hematopoietic stem cells (7) 7
prognosis (7) 7
retrospective studies (7) 7
survival (7) 7
transplantation conditioning - methods (7) 7
acute myeloid-leukemia (6) 6
analysis (6) 6
hematologic neoplasms - therapy (6) 6
leukemia (6) 6
multiple myeloma - drug therapy (6) 6
survival rate (6) 6
aged, 80 and over (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
bone marrow (5) 5
graft vs host disease - etiology (5) 5
graft-versus-host disease (5) 5
hematologic neoplasms - mortality (5) 5
hemic and lymphatic diseases (5) 5
incidence (5) 5
multiple myeloma - genetics (5) 5
multiple myeloma - pathology (5) 5
thalidomide (5) 5
therapy (5) 5
antineoplastic agents - therapeutic use (4) 4
care and treatment (4) 4
chemotherapy (4) 4
clinical-trials (4) 4
combined modality therapy (4) 4
criteria (4) 4
disease progression (4) 4
graft vs host disease - mortality (4) 4
graft vs host disease - pathology (4) 4
gvhd (4) 4
immunosuppressive agents - therapeutic use (4) 4
monoclonal gammopathy (4) 4
multiple myeloma - mortality (4) 4
myelodysplastic syndrome (4) 4
original and brief reports (4) 4
patients (4) 4
progression (4) 4
prophylaxis (4) 4
prospective studies (4) 4
t cells (4) 4
thalidomide - analogs & derivatives (4) 4
transplantation conditioning (4) 4
undetermined significance (4) 4
unrelated donors (4) 4
abridged index medicus (3) 3
acute disease (3) 3
allogeneic stem cell transplantation (3) 3
allogeneic transplantation (3) 3
amyloidosis (3) 3
blood (3) 3
bone-marrow (3) 3
bortezomib (3) 3
comorbidity index (3) 3
complications (3) 3
development and progression (3) 3
endoscopy (3) 3
flow-cytometry (3) 3
free light chains (3) 3
graft versus host disease (3) 3
graft vs host disease - diagnosis (3) 3
graft vs host disease - immunology (3) 3
graft vs host disease - prevention & control (3) 3
hematologic neoplasms - immunology (3) 3
hematologic neoplasms - pathology (3) 3
hematopoietic stem cell transplantation - methods (3) 3
hemopoiesis (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 438 - 447
Journal Article
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 08/2019, Volume 25, Issue 15, pp. 4616 - 4623
Purpose: The biologically active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3 (vit D), has immunoregulatory properties via binding vitamin D receptor... 
SURVIVAL | DENDRITIC CELLS | ONCOLOGY | PROSTATE-CANCER | REGULATORY T-CELLS | D DEFICIENCY | RISK | D-3 | GENE POLYMORPHISMS | ASSOCIATION | EXPRESSION | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 10, pp. 1580 - 1585
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 05/2018, Volume 24, Issue 5, p. 964
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.bbmt.2017.12.804 
Analysis | Immunotherapy | Transplantation | T cells | Hematopoietic stem cells
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 04/2019, Volume 104, Issue 5, pp. 929 - 936
The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with... 
SYSTEM | PROPHYLAXIS | IMPACT | PROGNOSIS | MONOSOMAL KARYOTYPE | ACUTE MYELOID-LEUKEMIA | MUTATIONS | OUTCOMES | CYTOMEGALOVIRUS | HEMATOLOGY | BLOOD
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 474 - 482
The current study was designed to assess the safety and efficacy of bortezomib in combination with fludarabine and melphalan as reduced intensity conditioning... 
graft‐versus‐host disease | multiple myeloma | conditioning regimen | bortezomib | transplantation | Conditioning regimen | Graft-versus-host disease | Transplantation | Bortezomib | Multiple myeloma | DIAGNOSED MULTIPLE-MYELOMA | PROGNOSTIC-FACTORS | BONE-MARROW-TRANSPLANTATION | AUTOLOGOUS TRANSPLANTATION | VERSUS-HOST-DISEASE | CHEMOTHERAPEUTIC-AGENTS | PLUS DEXAMETHASONE | TERM-FOLLOW-UP | STEM-CELL TRANSPLANTATION | HEMATOLOGY | graft-versus-host disease | T-CELLS | Graft vs Host Disease - epidemiology | Peripheral Nervous System Diseases - chemically induced | Apoptosis - drug effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Boronic Acids - adverse effects | Male | Transplantation, Autologous | Pyrazines - therapeutic use | Melphalan - therapeutic use | Boronic Acids - therapeutic use | Transplantation, Homologous | Protease Inhibitors - pharmacology | Multiple Myeloma - drug therapy | T-Lymphocyte Subsets - drug effects | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Maintenance Chemotherapy | Boronic Acids - administration & dosage | Transplantation Conditioning - methods | Protease Inhibitors - therapeutic use | Immunosuppressive Agents - pharmacology | Multiple Myeloma - surgery | Chemical and Drug Induced Liver Injury - etiology | Immunosuppressive Agents - administration & dosage | Hematologic Diseases - chemically induced | Reoperation | Combined Modality Therapy | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Drug Synergism | Cyclosporine - therapeutic use | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Immunosuppressive Agents - adverse effects | Vidarabine - administration & dosage | Pyrazines - pharmacology | Peripheral Blood Stem Cell Transplantation | Boronic Acids - pharmacology | Clinical trials | Product development | Index Medicus
Journal Article
Journal Article
Journal Article